United States

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates PGTI, AXNX, AVRO, CTLT

NEW YORK, Feb. 17, 2024 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

PGT Innovations, Inc. (NYSE: PGTI)’s sale to MITER Brands for $42.00 per share in cash. If you are a PGT shareholder, click here to learn more about your rights and options.

Axonics, Inc. (NASDAQ: AXNX)’s sale to Boston Scientific Corporation for $71.00 in cash per share. If you are an Axonics shareholder, click here to learn more about your rights and options.

AVROBIO, Inc. (NASDAQ: AVRO)’s merger with Tectonic Therapeutic, Inc. Upon completion of the proposed transaction, pre-merger AVROBIO shareholders are expected to own approximately 22.3% of the combined company. If you are an AVROBIO shareholder, click here to learn more about your rights and options.

Catalent, Inc. (NYSE: CTLT)’s sale to Novo Holdings for $63.50 per share in cash. If you are a Catalent shareholder, click here to learn more about your rights and options.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]  
https://www.halpersadeh.com

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button